You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Claims for Patent: 5,466,446


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,466,446
Title: Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
Abstract:Dermatological conditions are treated by topically applying to the affected area an effective amount of a combination benzoyl peroxide and clindamycin composition.
Inventor(s): Stiefel; Werner K. (Coral Gables, FL), Popp; Karl F. (Schodack Landing, NY)
Assignee: Stiefel Laboratories, Inc. (Coral Gables, FL)
Application Number:08/197,076
Patent Claims: 1. A topical gel composition for treating skin disorders involving the sebaceous glands and follicles in humans, said composition consisting essentially of an effective amount of a mixture of: (i) at least 4.5% by weight of benzoyl peroxide, and (ii) at least 0.9% by weight of clindamycin, admixed with a topically acceptable pharmaceutical carrier consisting essentially of about 0.04% disodium monolaurel sulfosuccinate, about 2.0% of a carbomer, about 0.1% of disodium ethylene diaminetetraacetic acid, about 0.1% of dimethicone, about 0.25% of hydrated silica, about 0.20% of poloxamer 182 and about 0.31% of sodium hydroxide by weight of said composition, wherein the composition is stable for at least 3 months at ambient temperature.

2. A method for treating skin disorders involving the sebaceous glands and follicles in humans which consists essentially of topically applying to affected skin an effective amount of a mixture of at least 4.5% by weight of benzoyl peroxide and at least 0.9% by weight of clindamycin admixed with a topically acceptable pharmaceutical carrier in gel form, consisting essentially of about 0.04% disodium monolaurel sulfosuccinate, about 2.0% of a carbomer, about 0.1% of disodium ethylene diaminetetraacetic acid, about 0.1% of dimethicone, about 0.25% of hydrated silica, about 0.20% of poloxamer 182 and about 0.31% of sodium hydroxide by weight of said composition.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.